Adenovirus-mediated gene therapy of experimental cerebral glioma in the rat;Thérapie génique du glioblastome cérébral par vecteur adénoviral. Modèle expérimental chez le rat

Chirurgie

Volumn 123, Issue 2, 1998, Pages 168-174

  Dufour, T ^a   Quillien, V ^b   Heresbach, N ^c   Denais, A ^c   Ferry, N ^b   Guegan, Y ^c  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Adenovirus; Gene therapy; Glioblastoma

Indexed keywords

ADENOVIRUS; ANIMAL; ARTICLE; BRAIN TUMOR; CANCER TRANSPLANTATION; CAUDATE NUCLEUS; CELL CULTURE; FISCHER 344 RAT; GENE THERAPY; GENE VECTOR; GENETICS; GLIOBLASTOMA; PATHOLOGY; RAT; WISTAR RAT; ANIMAL MODEL; CELL TRANSPLANTATION; CONTROLLED STUDY; GENE TRANSFER; GLIOMA; GLIOSARCOMA; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; MALE; NONHUMAN; STEREOTAXIC SURGERY;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; CAUDATE NUCLEUS; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; RATS, WISTAR; TUMOR CELLS, CULTURED;

BETA GALACTOSIDASE; GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

EID: 0031745245     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4001(98)80102-5     Document Type: Article

References (23)

1. Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia 1995; 15 : 211-21
2. Black P McL. Brain tumors. N Engl J Med 1991 ; 324 : 1471-6
3. Marcel T, Grausz JD. The TMC worldwide gene therapy enrollment report. Paris : TMC development ; 1996
4. Yoshii Y, Maki Y, Tsuboi K, Tomono Y, Nakagawa K, Hoshino T. Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors. JNeurosurg 1986 ; 65 : 659-63
5. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989 ; 7 : 980-90
6. Mittal SK, Bett AJ, Prevec L, Graham FL. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta galactosidase genes as reporters. Virology 1995 ; 210 : 226-30
7. Weizsaecker M, Deen DF, Rosenblum ML, Hoshino T, Gutin PH, Barker M. The 9L rat brain tumor: description and application of an animal model. J Neurol 1981 ; 224 : 183-92
8. Vincent AJPE, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJJ et al. Herpes simplex virus thymidine kinase gene therapy fos rat malignant brain tumors. Hum Gene Ther 1996 ; 7 : 197-205
9. Viola JJ, Ram Z, Walbridge S, Oshiro EM, Trapnell B, Tao-Cheng JH et al. Adenovirally mediated gene transfer into experimental solid brain tumor and leptomeningeal cancer cells. J Neurosurg 1995 ; 82 : 70-6
10. Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford RK, Kowall NW et al. Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus. Herpes Simplex Virus, and Retrovirus Vectors. Hum Gene Ther 1994 ; 5 : 183-91
11. Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994 ; 91 : 4407-11
12. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993 ; 259 : 988-90
13. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet 1993 ; 3 : 224-8
14. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992 ; 256 : 1550-2
15. Li Bi W, Parysek LM, Warnick R, Stambrook P. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993 ; 4 : 725-31
16. Shinoura N, Chen L, Wani MA, Kim YG, Larson JJ, Warnick RE et al. Protein and messenger RNA expression of connexin 43 in astrocytomas: implications in brain tumor gene therapy. J Neurosurg 1996 ; 84 : 839-46
17. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 1994 ; 81 : 256-60
18. Colak A, Goodman JC, Chen SH, Woo SLC, Grossman RG, Shine HD. Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res 1995 ; 691 : 76-82
19. Elshami AA, Kucharczuk JC, Sterman DH, Smythe WR, Hwang HC, Amin KM et al. The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann Surg 1995 ; 222 : 299-307
20. Barba D, Hardin J, Sadelain M, Gage FH. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 1994 ; 91 : 4348-52
21. Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SLC, Grossman RG et al. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 1994 ; 39 : 506-11
22. Maron A, Gustin T, Le Roux A, Mottet I, Dedieu JF, Brion JP et al. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long term follow-up by magnetic resonance imaging.Gene Ther 1996 ; 3 : 315-22
23. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 1996 ; 56 : 4087-95